Noosa News
There is a problem with AstraZeneca … but it’s not clotting
It’s not about the risk of clotting, which everyone agrees is very rare, it’s about effectiveness. From the start, the AstraZeneca vaccine has performed poorly when compared against the mRNA vaccines, such as Pfizer and Moderna. In later trials, when jabs were spaced out to 12 weeks apart,…
Click here to view the original article.
Continue Reading
-
Noosa News19 hours agoRights lecture focuses on older people – Proctor
-
Noosa News18 hours agoMaroons State of Origin squad set to include three debutants as Queensland counts the cost of injury
-
General13 hours agoCounter-terrorism expert criticises ‘skillset’ of Westfield security guard during Westfield Bondi Junction stabbing
-
General24 hours agoStarlight recipient-turned-volunteer ‘pays it forward’